Michael J Kovacs
Overview
Explore the profile of Michael J Kovacs including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
97
Citations
3856
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bezerra O, Rodger M, Munsch G, Kovacs M, Le Gal G, Morange P, et al.
J Thromb Haemost
. 2025 Jan;
PMID: 39848545
Background: Whether to stop oral anticoagulants after a first unprovoked venous thromboembolism (VTE) is challenging, partially due to an intriguingly higher risk of VTE recurrence (rVTE) in men after therapy...
2.
Wang T, Delluc A, Cervi A, Hill D, Kovacs M, Seguin C, et al.
Thromb Res
. 2023 Nov;
233:10-13.
PMID: 37984078
No abstract available.
3.
Xu Y, Khan F, Kovacs M, Sabri E, Carrier M, Righini M, et al.
Thromb Res
. 2023 Oct;
231:32-38.
PMID: 37801772
Introduction: While several risk stratification tools have been developed to predict the risk of recurrence in patients with an unprovoked venous thromboembolism (VTE), only 1 in 4 patients are categorized...
4.
Pradier M, Rodger M, Ghanima W, Kovacs M, Shivakumar S, Kahn S, et al.
Thromb Haemost
. 2023 Feb;
123(7):692-699.
PMID: 36809776
Objective: The SOX-PTS, Amin, and Méan models are three different clinical prediction scores stratifying the risk for postthrombotic syndrome (PTS) development in patients with acute deep vein thrombosis (DVT) of...
5.
Robin P, Le Pennec R, Eddy M, Sikora L, Le Roux P, Carrier M, et al.
J Thromb Haemost
. 2023 Feb;
21(6):1519-1528.e2.
PMID: 36740040
We aimed to assess the relationship between residual pulmonary vascular obstruction (RPVO) on planar lung scan after completion of at least 3 months of anticoagulant therapy for acute pulmonary embolism...
6.
Caiano L, Kovacs M, Lazo-Langner A, Anderson D, Kahn S, Shah V, et al.
J Thromb Haemost
. 2023 Jan;
21(3):553-558.
PMID: 36710196
Background: Thrombophilia predisposes to venous thromboembolism (VTE) because of acquired or hereditary factors. Among them, it has been suggested that gene mutations of the factor V Leiden (FVL) or prothrombin...
7.
Bistervels I, Bavalia R, Beyer-Westendorf J, Ten Cate-Hoek A, Schellong S, Kovacs M, et al.
Res Pract Thromb Haemost
. 2022 Aug;
6(5):e12748.
PMID: 35992565
Background: Postthrombotic syndrome (PTS) is a long-term complication after deep vein thrombosis (DVT) and can affect quality of life (QoL). Pathogenesis is not fully understood but inadequate anticoagulant therapy with...
8.
Wells P, Tritschler T, Khan F, Anderson D, Kahn S, Lazo-Langner A, et al.
Blood Adv
. 2022 Jun;
6(15):4605-4616.
PMID: 35679460
No clinical prediction model has been specifically developed or validated to identify patients with unprovoked venous thromboembolism (VTE) who are at high risk of major bleeding during extended anticoagulation. In...
9.
Delluc A, Ghanima W, Kovacs M, Shivakumar S, Kahn S, Sandset P, et al.
Thromb Res
. 2022 Mar;
213:119-124.
PMID: 35344784
Background: Post-thrombotic syndrome (PTS) is one of the most frequent complications of venous thromboembolism (VTE) leading to considerable morbidity and cost. Apart from appropriate anticoagulation, there is no drug or...
10.
Ng S, Rodger M, Ghanima W, Kovacs M, Shivakumar S, Kahn S, et al.
Thromb Haemost
. 2022 Jan;
122(8):1379-1383.
PMID: 35021257
Introduction: The Villalta scale is the endorsed tool to diagnose and grade the severity of postthrombotic syndrome (PTS); however, assessing presence and severity of PTS is time-consuming and relies on...